House Bill
|
4825
|
An Act extending the authorization for the use of certain discount vouchers for prescription drugs
|
Support
|
$0.00
|
n/a
|
House Bill
|
2206
|
An Act relative to retail pharmacy discounts and co-pay assistance
|
Support
|
$0.00
|
n/a
|
House Bill
|
4617
|
An Act establishing the Honorable Peter V. Kocot Act to enhance access to high quality, affordable and transparent healthcare in the Commonwealth
|
Support
|
$0.00
|
n/a
|
House Bill
|
491
|
An Act relative to transparency and access in healthcare
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Opposition to the published list of stakeholders scheduled to testify at the annual cost trends hearings; Massachusetts Health Policy Council
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Opposition to the MassHealth 1115 waiver request by the Governor & Massachusetts Executive Office of Health and Human Services; specifically, the pharmacy restrictions of a closed formulary and drug exclusion based on Food and Drug Administration accelerated approval; Governor & Massachusetts Executive Office of Health and Human Services
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3223
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
4605
|
An Act establishing the Honorable Peter V. Kocot Act to enhance access to high quality, affordable and transparent healthcare in the Commonwealth
|
Support
|
$0.00
|
n/a
|
House Bill
|
620
|
An Act relative to health care cost transparency
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Drug industry representation for Health Policy Council; Health Policy Council
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
2202
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
2202
|
An Act furthering health empowerment and affordability by leveraging transformative health care.
|
Oppose
|
$0.00
|
n/a
|
Executive
|
|
Discussions with the Health Policy Council and Advisory Council and Center for Health Information and Analysis with a focus on health care price variation, gross and net Rx drug costs to the state, as well as the establishment and implementation of Accountable Care Organizations. My interactions are with Health Policy Council Board Members, Health Policy Council Staff, and the staff from the Center of Health Information Analysis.
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
652
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
4639
|
An Act establishing the Honorable Peter V. Kocot Act to enhance access to high quality, affordable and transparent healthcare in the Commonwealth
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
2625
|
An Act relative to economic development in the commonwealth
|
Support
|
$0.00
|
n/a
|
House Bill
|
627
|
An Act establishing a student tuition recovery fund
|
Neutral
|
$0.00
|
n/a
|
Executive
|
|
Direct involvement with the State’s Health Policy Commission as a formal member of the Health Policy Commission’s Advisory Council in discussions to implement the Massachusetts Health Care Cost Containment Law (Chapter 224).
|
Neutral
|
$0.00
|
n/a
|
Senate Bill
|
635
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
1228
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
n/a
|
| | |
Total amount
|
$0.00
| |